These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24886600)

  • 1. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
    Knevel R; de Rooy DP; Saxne T; Lindqvist E; Leijsma MK; Daha NA; Koeleman BP; Tsonaka R; Houwing-Duistermaat JJ; Schonkeren JJ; Toes RE; Huizinga TW; Brouwer E; Wilson AG; van der Helm-van Mil AH
    Arthritis Res Ther; 2014 May; 16(3):R108. PubMed ID: 24886600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
    Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
    J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.
    Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study.
    Knevel R; Krabben A; Brouwer E; Posthumus MD; Wilson AG; Lindqvist E; Saxne T; de Rooy D; Daha N; van der Linden MP; Stoeken G; van Toorn L; Koeleman B; Tsonaka R; Zhernakoza A; Houwing-Duistermaat JJ; Toes R; Huizinga TW; van der Helm-van Mil A
    Ann Rheum Dis; 2012 Oct; 71(10):1651-7. PubMed ID: 22440823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.
    Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kamatani N; Kotake S
    Clin Rheumatol; 2007 Dec; 26(12):2137-2141. PubMed ID: 17876645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
    Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
    Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
    Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
    Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
    de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M; Lin L; Cui H
    Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Variant Interactions in
    Chen B; Du Z; Dong X; Li Z; Wang Q; Chen G; Zhang G; Song Y
    DNA Cell Biol; 2019 Jul; 38(7):734-746. PubMed ID: 31149839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report.
    Zavala-Cerna MG; Moran-Moguel MC; Cornejo-Toledo JA; Gonzalez-Montoya NG; Sanchez-Corona J; Salazar-Paramo M; Nava-Zavala AH; Aguilar-Chavez EA; Alcaraz-Lopez MF; Gonzalez-Sanchez AG; Gonzalez-Lopez L; Gamez-Nava JI
    J Immunol Res; 2015; 2015():376197. PubMed ID: 26065000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Genetic Variants of
    Wang CM; Tsai SC; Lin JC; Wu YJ; Wu J; Chen JY
    Mediators Inflamm; 2019; 2019():8029863. PubMed ID: 31015798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.
    Knevel R; Krabben A; Wilson AG; Brouwer E; Leijsma MK; Lindqvist E; de Rooy DP; Daha NA; van der Linden MP; Tsonaka S; Zhernakova A; Westra HJ; Franke L; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Saxne T; van der Helm-van Mil AH
    Arthritis Rheum; 2013 Mar; 65(3):582-9. PubMed ID: 23440692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
    Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
    J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population.
    Song Y; Du ZW; Yang QW; Ren M; Wang QY; Wang A; Chen GY; Zhao HY; Yu T; Zhang GZ
    Int J Med Sci; 2017; 14(7):690-697. PubMed ID: 28824302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
    Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
    J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment.
    Wielińska J; Kolossa K; Świerkot J; Dratwa M; Iwaszko M; Bugaj B; Wysoczańska B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2020 Aug; 68(4):24. PubMed ID: 32815001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.
    Haynes DR; Crotti TN; Loric M; Bain GI; Atkins GJ; Findlay DM
    Rheumatology (Oxford); 2001 Jun; 40(6):623-30. PubMed ID: 11426018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.